Not logged in Share Save
Adjuvant immunotherapy in patients with resected gastric and oesophagogastric junction cancer following preoperative chemotherapy with high risk for recurrence (ypND and/or R1): European Organisation of Research and Treatment of Cancer (EORTC) 1707 VESTIGE study Lordick, F.; Mauer, M. E.; Stocker, G.; Cella, C. A.; Ben-Aharon, I.; Piessen, G.; Wyrwicz, L.; Al-Haidari, G.; Fleitas-Kanonnikoff, T.; Boige, V.; Obermannova, R. Lordick; Martens, U. M.; Gomez-Martin, C.; Thuss-Patience, P.; Arrazubi, V.; Avallone, A.; Shiu, K. K.; Artru, P.; Brenner, B.; Sanchez, C. Buges; Chau, I.; Lorenzen, S.; Daum, S.; Sinn, M.; Merelli, B.; van Grieken, N. C. T.; Nilsson, M.; Collienne, M.; Giraut, A.; Smyth, E. Share Save
Risk of bowel obstruction in patients with colon cancer responding to immunotherapy: an international case series Platt, J. R.; Allotey, J.; Alouani, E.; Glasbey, J.; Intini, R.; Lonardi, S.; Mazzoli, G.; Militello, A. M.; Modest, D. P.; Palle, J.; Pietrantonio, F.; Riyad, K.; Samuel, L.; V. Schulze, A.; Shiu, K. K.; Taieb, J.; Tolan, D. J. M.; West, N. P.; Westwood, A. C.; Williams, C. J. M.; Seligmann, J. F. Share Save
Genetic and immune landscape evolution in MMR-deficient colorectal cancer Challoner, Benjamin R.; Woolston, Andrew; Lau, David; Buzzetti, Marta; Fong, Caroline; Barber, Louise J.; Anandappa, Gayathri; Crux, Richard; Assiotis, Ioannis; Fenwick, Kerry; Begum, Ruwaida; Begum, Dipa; Lund, Tom; Sivamanoharan, Nanna; Sansano, Harold B.; Domingo-Arada, Melissa; Tran, Amina; Pandha, Hardev; Church, David; Eccles, Bryony; Ellis, Richard; Falk, Stephen; Hill, Mark; Krell, Daniel; Murugaesu, Nirupa; Nolan, Luke; Potter, Vanessa; Saunders, Mark; Shiu, Kai-Keen; Guettler, Sebastian; Alexander, James L.; Lazare-Iglesias, Hector; Kinross, James; Murphy, Jamie; von Loga, Katharina; Cunningham, David; Chau, Ian; Starling, Naureen; Ruiz-Banobre, Juan; Dhillon, Tony; Gerlinger, Marco Share Save
Share Save
EORTC 1707 VESTIGE: Adjuvant immunotherapy in patients (pts) with resected gastroesophageal adenocarcinoma (GEA) following preoperative chemotherapy with high risk for recurrence (ypN+ and/or R1)-an open-label randomized controlled phase II study Smyth, E.; Mauer, M.; Cella, C.; Ben-Aharon, I.; Piessen, G.; Wyrwicz, L.; Al-Haidari, G.; Kanonnikoff, T. Fleitas; Boige, V.; Stahl, M.; Martens, U.; Obermannova, R.; Gomez-Martin, C.; Thuss-Patience, P.; Arrazubi, V.; Avallone, A.; Shiu, K.; Collienne, M.; Giraut, A.; Lordick, F. Share Save
Additional data from the KEYNOTE-859 study of pembrolizumab plus chemotherapy versus placebo plus chemotherapy for advanced HER2-negative gastric or gastroesophageal junction (G/GEJ) cancer Wyrwicz, L.; Oh, D.; Weber, P.; Bai, Y.; Ryu, M.; Lee, J.; Rivera, F.; Alves, G. Vasconcelos; Garrido, M.; Shiu, K.; Fernandez, M. Gonzalez; Li, J.; Lowery, M.; Cil, T.; Cruz, F.; Qin, S.; Yin, L.; Bordia, S.; Bhagia, P.; Rha, S. Share Save
Lenvatinib plus pembrolizumab versus standard of care for previously treated metastatic colorectal cancer (mCRC): the phase 3 LEAP-017 study Kawazoe, A.; Xu, R.; Passhak, M.; Teng, H.; Shergill, A.; Gumus, M.; Qvortrup, C.; Stintzing, S.; Towns, K.; Kim, T.; Shiu, K.; Cundom, J.; Ananda, S.; Lebedinets, A.; Fu, R.; Jain, R.; Adelberg, D.; Heinemann, V.; Yoshino, T.; Elez, E. Share Save
Pembrolizumab vs chemotherapy in MSI-H/dMMR metastatic colorectal cancer: KEYNOTE-177 final analysis Asia subgroup Yoshino, Takayuki; Andre, Thierry; Shiu, Kai-Keen; Kim, Tae Won; Jensen, Benny Vittrup; Jensen, Lars Henrik; Punt, Cornelius J. A.; Smith, Denis; Garcia-Carbonero, Rocio; Gibbs, Peter; Le Dung, T.; Adachi, Noriaki; Fogelman, David; Marinello, Patricia; Diaz, Luis A., Jr. Share Save
Trifluridine/Tipiracil in Metastatic Colorectal Cancer: A UK Multicenter Real-world Analysis on Efficacy, Safety, Predictive and Prognostic Factors Stavraka, Chara; Pouptsis, Athanasios; Synowiec, Alicja; Angelis, Vasileios; Satterthwaite, Liyana; Khan, Sam; Chauhan, Meera; Holden, Chloe; Young, Sally; Karampera, Christina; Martinou, Maria; Mills-Baldock, Tina; Baxter, Mark; Barry, Ainsley; Eccles, Bryony; Iveson, Timothy; Shiu, Kai-Keen; Hill, Mark; Abdel-Raouf, Sherif; Graham, Janet Shirley; Thomas, Anne; Ross, Paul J. Share Save
Pembrolizumab vs chemotherapy for MSI-high/dMMR metastatic colorectal cancer: Asia subgroup of phase 3 KEYNOTE-177 Yoshino, Takayuki; Kim, Tae Won; Yong, Wei Peng; Shiu, Kai-Keen; Jensen, Benny Vittrup; Jensen, Lars Henrik; Smith, Denis; Garcia-Carbonero, Rocio; Alcaide-Garcia, Julia; Gibbs, Peter; De la Fouchardiere, Christelle; Rivera, Fernando; Elez, Elena; Bendell, Johanna; Le, Dung T.; Yang, Ping; Farooqui, Mohammed; Marinello, Patricia; Diaz, Luis A.; Andre, Thierry Share Save
Final overall survival for the phase 3 KN177 study: Pembrolizumab versus chemotherapy in microsatellite instability-high/mismatch repair deficient metastatic colorectal cancer Andre, T.; Shiu, K.; Kim, T.; Jensen, B.; Jensen, L.; Punt, C.; Smith, D.; Garcia-Carbonero, R.; Alcaide Garcia, J.; Gibbs, P.; De la Fouchardiere, C.; Rivera Herrero, F.; Elez, E.; Bendell, J.; Le, D.; Yoshino, T.; Zhong, W.; Fogelman, D.; Marinello, P.; Diaz, L., Jr. Share Save
Pembrolizumab in Microsatellite-Instability-High Advanced Colorectal Cancer Andre, T.; Shiu, K-K; Kim, T. W.; Jensen, B., V; Jensen, L. H.; Punt, C.; Smith, D.; Garcia-Carbonero, R.; Benavides, M.; Gibbs, P.; de la Fouchardiere, C.; Rivera, F.; Elez, E.; Bendell, J.; Le, D. T.; Yoshino, T.; Van Cutsem, E.; Yang, P.; Farooqui, M. Z. H.; Marinello, P.; Diaz, L. A., Jr. Share Save
Outcomes of the 2019 novel coronavirus in patients with or without a history of cancer: a multi-centre North London experience Joharatnam-Hogan, Nalinie; Hochhauser, Daniel; Shiu, Kai-Keen; Rush, Hannah; Crolley, Valerie; Wilson, William; Sharma, Anand; Muhammad, Aun; Anwar, Muhammad; Vasdev, Nikhil; Goldstein, Robert; Kantser, Ganna; Saha, Aramita; Raja, Fharat; Bridgewater, John; Khan, Khurum Share Save
Share Save
Gastric Inflammatory Prognostic Index (GIPI) in Patients with Metastatic Gastro-Esophageal Junction/Gastric Cancer Treated with PD-1/PD-L1 Immune Checkpoint Inhibitors Formica, Vincenzo; Morelli, Cristina; Patrikidou, Anna; Murias, Carmen; Butt, Sabeeh; Nardecchia, Antonella; Lucchetti, Jessica; Renzi, Nicola; Shiu, Kai-Keen; Roselli, Mario; Arkenau, Hendrik-Tobias Share Save
Share Save
Share Save
FOCUS4-D: Results from a randomised, placebo controlled trial (RCT) of AZD8931 (an inhibitor of signalling by HER1, 2, and 3) in patients (pts) with advanced or metastatic colorectal cancer (aCRC) in tumours that are wildtype (wt) for BRAF, PIK3CA, KRAS & NRAS Adams, R. A.; Brown, E.; Brown, L.; Butler, R.; Falk, S.; Fisher, D.; Kaplan, R.; Quirke, P.; Richman, S.; Samuel, L.; Seligmann, J.; Seymour, M.; Shiu, K. K.; Wasan, H.; Wilson, R.; Maughan, T. Share Save
Adenoid cystic carcinomas constitute a genomically distinct subgroup of triple-negative and basal-like breast cancers Wetterskog, Daniel; Angeles Lopez-Garcia, Maria; Lambros, Maryou B.; A'Hern, Roger; Geyer, Felipe C.; Milanezi, Fernanda; Cabral, Maria C.; Natrajan, Rachael; Gauthier, Arnaud; Shiu, Kai-Keen; Orr, Nicholas; Shousha, Sami; Gatalica, Zoran; Mackay, Alan; Palacios, Jose; S Reis-Filho, Jorge; Weigelt, Britta Share Save
.png){kind=icon}
.png){kind=icon}
Not logged in.png){kind=icon}
.png){kind=icon}
.png){kind=icon}
.png){kind=icon}
.png){kind=icon}
